Our results showed that high CTR1 expression was significantly associated with a favorable OS, PFS, DFS and TR, suggesting that CTR1 is a potential prognostic factor for survival in cancer patients underwent chemotherapy and a treatment target for overcoming platinum resistance. This evidence concerns the gene SLC31A1 and cancer.